| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/28/1998 | EP0820769A2 Use of benzothiophenes for the manufacture of a medicament for the treatment of diseases associated with an excess of tachykinis |
| 01/28/1998 | EP0820515A1 Phospholipase c homolog |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820316A1 Coating for bio-material insertable into the bloodstream or tissue of the human body |
| 01/28/1998 | EP0820308A2 Conjugate for treating inflammatory, infectious and/or skin diseases |
| 01/28/1998 | EP0820306A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent |
| 01/28/1998 | EP0820305A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 01/28/1998 | EP0820303A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 01/28/1998 | EP0820291A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 01/28/1998 | EP0820286A1 Treatment for ocular inflammation |
| 01/28/1998 | EP0820281A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
| 01/28/1998 | EP0639970B1 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 01/28/1998 | EP0608320B1 Enhanced skin penetration system for improved topical delivery of drugs |
| 01/28/1998 | CN1171738A Pharmaceutical composition |
| 01/28/1998 | CN1171238A Method for enhancing anticarcinogenic effect |
| 01/27/1998 | US5712370 Erythropoietin (EPO) peptides and antibodies directed against these |
| 01/27/1998 | US5712307 Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof |
| 01/27/1998 | US5712295 Insecticides and parasiticides for plant protection |
| 01/27/1998 | US5712293 Gastrointestinal disorders |
| 01/27/1998 | US5712265 Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders |
| 01/27/1998 | US5712115 Polynucleotide encoding polypeptide with amino acid sequences |
| 01/27/1998 | US5712111 DNA encoding bradykinin B1 receptor |
| 01/22/1998 | WO1998002539A1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 01/22/1998 | WO1998002240A1 Preservation by foam formation |
| 01/22/1998 | WO1998002183A1 Medicinal compositions |
| 01/22/1998 | WO1998002182A1 Oral pharmaceutical combinations of nsaids with terpenoids |
| 01/22/1998 | WO1998002178A1 Methods of controlling axonal growth |
| 01/22/1998 | WO1998002159A1 Novel treatment of leptine resistance |
| 01/22/1998 | WO1998002158A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 01/22/1998 | WO1998002038A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | DE19628776A1 Oral applizierbare Granulate von Hexahydropyrazinderivaten Administered Orally granules of Hexahydropyrazinderivaten |
| 01/22/1998 | CA2295500A1 Methods of controlling axonal growth |
| 01/22/1998 | CA2260269A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 01/22/1998 | CA2260233A1 A scalable method of preserving biologically active materials by desiccation |
| 01/22/1998 | CA2260044A1 Novel treatment of leptine resistance |
| 01/21/1998 | EP0819436A2 Pharmaceutical and dietary composition containing sodium-, potassium-, magnesium- and calcium-ions and enzyme activators |
| 01/21/1998 | EP0819433A2 Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin |
| 01/21/1998 | EP0819432A1 Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
| 01/21/1998 | EP0819169A1 Methods for screening compounds for estrogenic activity |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0819004A1 Pharmaceutical composition containing proton pump inhibitors |
| 01/21/1998 | EP0819003A1 A method for the treatment of macular degeneration |
| 01/21/1998 | EP0701443B1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 01/21/1998 | EP0527917B1 Use of adenosine and adenosine derivatives for anesthesia |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171051A Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception |
| 01/21/1998 | CN1170575A Treatment and prophylaxis of pancreatitis |
| 01/20/1998 | US5710178 Aryl- and aryloxyalkanoic acids |
| 01/20/1998 | US5710175 Optionally acylated 1-alkenyl monoglyceride |
| 01/20/1998 | US5710134 Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5709869 Intradermal delivery of lidocaine |
| 01/20/1998 | CA2059000C Fused-ring aryl substituted imidazoles |
| 01/18/1998 | CA2195606A1 Method of increasing efficacy of cancer drugs |
| 01/15/1998 | WO1998001563A2 Adenovirus e4 proteins for inducing cell death |
| 01/15/1998 | WO1998001467A2 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | WO1998001440A2 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof |
| 01/15/1998 | WO1998001425A1 1,4-di-sustituted piperidines as muscarinic antagonists |
| 01/15/1998 | WO1998001159A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | WO1998001157A1 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
| 01/15/1998 | WO1998001154A2 Treatment and diagnosis of infections of gram positive cocci |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1998001143A1 Use of artichoke (cynara) extracts |
| 01/15/1998 | WO1998001136A1 Formulations of vesicant drugs and methods of use thereof |
| 01/15/1998 | WO1998001123A1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 01/15/1998 | CA2260128A1 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof |
| 01/15/1998 | CA2259149A1 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/15/1998 | CA2259010A1 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
| 01/15/1998 | CA2257563A1 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/14/1998 | EP0817967A1 Insulin mimetic and enhancer assay |
| 01/14/1998 | EP0817864A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
| 01/14/1998 | EP0817861A1 Gene transfer into the kidney |
| 01/14/1998 | EP0817648A1 Vascular endothelial cell growth factor antagonists |
| 01/14/1998 | EP0817643A1 Compounds and compositions for delivering active agents |
| 01/14/1998 | EP0817636A1 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817625A2 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid |
| 01/14/1998 | EP0817622A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 01/14/1998 | EP0817618A1 Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
| 01/14/1998 | EP0642336B1 Use of nsiad in the treatment of dementia |
| 01/14/1998 | EP0603301B1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 01/14/1998 | EP0437488B1 Animal model for human disease |
| 01/14/1998 | CN1170366A Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 01/14/1998 | CN1170364A Liposome eye drops |
| 01/13/1998 | US5708147 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 01/13/1998 | US5708025 By inducing production of fetal hemoglobins by administering specified aryl acids, derivatives, salts |
| 01/13/1998 | US5708023 Nonirritating gel for skin |
| 01/13/1998 | US5708017 Omeprazole pastes with thickeners |
| 01/13/1998 | US5707999 Urogenital disorders |
| 01/13/1998 | US5707975 Itraconazole or saperconazole, hydroxypropyl-b-cyclodextrin solubilizer |
| 01/13/1998 | US5707973 Sulfated polysaccharids for treatment or prevention of thromboses |
| 01/13/1998 | US5707971 Modulation of glycolytic ATP production |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707795 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/13/1998 | US5707652 Methods of treating circadian rhythm phase disorders |
| 01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 01/08/1998 | WO1998000405A1 Pharmaceutical preparation |